A new device that is small but the difference it is making for patients at Saint Luke's Mid America Heart Institute, is huge. The COAPT trial, with the device called the MitraClip, has game changing findings for patients with advanced heart failure. Saint Luke’s Mid America Heart Institute was one of the leading participating trial sites for the COAPT trial and heavily participated in the research and findings. And those findings showed incredibly promising outcomes for patients with severe heart failure, including reduced hospitalizations due to heart failure.
The MitraClip is an minimally invasive procedure and an alternative to open heart surgery, which not everyone is a candidate for, and has a reduced recovery time with great benefits for the patient.
KCTV5's Jessica Reyes spoke with Dr. Adnan Chhatriwalla, Saint Luke's interventional cardiologist, who explained how this new device helps heart failure patients with mitral valve regurgitation live a better quality of life.
Watch the next interview to see the difference the MitraClip has made in one patients life.
Hear when the MitraClip could be available to all heart failure patients.
Watch the full story, below.